LXXGF - LexaGene Holdings Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development5,384.2132,486.036446.652446.652
Selling General and Administrative2,938.2711,491.839344.62455.988
Non Recurring----
Total Operating Expenses8,322.4843,977.875978.3159.338
Operating Income or Loss-8,322.484-3,977.875-978.31-59.338
Income from Continuing Operations
Total Other Income/Expenses Net1.11-27.577-3,504.905-0.061
Earnings Before Interest and Taxes-8,322.484-3,977.875-978.31-59.338
Interest Expense----
Income Before Tax-8,321.374-4,005.452-4,483.215-59.399
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-8,321.374-4,005.452-4,483.215-59.399
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,321.374-4,005.452-4,483.215-59.399
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,321.374-4,005.452-4,483.215-59.399